Ann: Trading Halt, page-22

I wasn't sure if they were doing one of the conference-wide presentations or not, but I did look at the list of participating companies (http://events.ebdgroup.com/bts/core/participating-companies2023.php) and found them listed, which means that they were there to meet for potential partnering activities.

It seems like the scheduling of Biotech Showcase partnership talks (where interested companies contact each other to reserve a time to talk at the actual conference) began at the end of November (https://www.azbio.org/events/2023-biotech-showcase). It's likely that this would be considered insider knowledge (especially if you had a promising lineup of interested partnering companies), so this may have prevented any insider stock purchases over the past couple of months.

It seems like the Biotech Showcase had in-person partnering meetings from January 9 to January 11 in the US, and then will have virtual partnering meetings on January 18 and 19. Since the announcement fell on the morning of January 12 in Australia, this seems to correspond with the end of the in-person partnering meetings. I take this to likely mean there was at least one interested party (that Kazia found to have an acceptable proposal) by the end of the in-person meetings.

Of course, on the other hand, there is the possibility that they had some sort of back-up deal in case there wasn't an interested party at the Biotech Showcase meetings, and if they completed their in-person meetings without a mutually agreeable deal, and didn't have any virtual meetings set up, then they could have pulled the trigger on the back-up deal instead.